Client News

Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent

Mainz Biomed Provides Review of 2025 Highlights

InflaRx Provides Update on Phase 3 Data Analyses for Vilobelimab in Pyoderma Gangrenosum

FDA approves another interchangeable Ranibizumab Biosimilar, Nufymco® – Strengthening US Presence with Zydus as Commercialization Partner

Abivax to be Added to Nasdaq Biotechnology Index

CARBIOS maintains its commitment to build the Longlaville plant and adjusts its timeline

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings

Secarna Pharmaceuticals and Protalix Biotherapeutics Enter into Collaboration and Option Agreement

Topadur Appoints Matthias Schäfer as Chief Executive Officer to Lead Next Phase of Company Growth

AFYREN awarded Silver Medal by EcoVadis for CSR performance, ranking in the top 8% worldwide